University Clinic of Medicine, Cantonal Hospital Baselland, Liestal, Switzerland.
Allergy Unit, Department of Dermatology, University Hospital Basel, Switzerland.
Swiss Med Wkly. 2019 Sep 2;149:w20100. doi: 10.4414/smw.2019.20100. eCollection 2019 Aug 26.
Asthma is associated with bronchial hyperresponsiveness, assessed by bronchial provocation tests such as the mannitol test. We aimed to assess the data on sensitivity and specificity of the mannitol test in diagnosing asthma.
We searched electronically the Medline, Embase and Central databases from 1997 to 2019.
Inclusion criteria were the assessment of the validity of the mannitol test. Risk of bias was assessed using the Quality Assessment of Diagnostic Accuracy Studies tool (QUADAS-2). Data were extracted according to a prespecified list and analysed qualitatively.
A total of 27 studies (4589 individuals, age 6–85 years, cross-sectional [n = 18] and case-controlled [n = 9] study design) were included. Overall sensitivity and specificity ranged from 8% (95% confidence interval [CI] 1–27) to 100% (95% CI 93–100) and 75% (95% CI 67–82) to 100% (95% CI 85–100). Excluding case-controlled design, studies conducted in a clinical setting showed a range from 19% (95% CI 14–27) to 91% (95% CI 59–100) for sensitivity and from 75% (95% CI 67–82) to 100% (95% CI 80–100) for specificity. Heterogeneity was high owing to differences in the populations examined and the methods used.
Studies on the accuracy of the mannitol test were heterogeneous. Overall specificity was higher than sensitivity and therefore the mannitol test seems to be a suitable diagnostic tool to confirm asthma. However, the high level of heterogeneity among the included studies makes a conclusive statement on the accuracy of the mannitol test difficult and further research is needed. As bronchial provocation tests can be especially useful in patients with an intermediate probability of asthma diagnosis, further studies are needed that include subjects with asthma symptoms but intermediate probability of asthma diagnosis.
哮喘与支气管高反应性有关,可通过甘露醇试验等支气管激发试验进行评估。本研究旨在评估甘露醇试验诊断哮喘的敏感性和特异性数据。
我们从 1997 年至 2019 年在 Medline、Embase 和中央数据库中进行了电子检索。
纳入标准为评估甘露醇试验的有效性。使用诊断准确性研究质量评估工具(QUADAS-2)评估偏倚风险。根据预设清单提取数据,并进行定性分析。
共纳入 27 项研究(4589 人,年龄 6-85 岁,横断面[ n = 18]和病例对照[ n = 9]研究设计)。总体敏感性和特异性范围为 8%(95%置信区间 [CI] 1-27)至 100%(95%CI 93-100)和 75%(95%CI 67-82)至 100%(95%CI 85-100)。排除病例对照设计后,在临床环境中进行的研究显示敏感性范围为 19%(95%CI 14-27)至 91%(95%CI 59-100),特异性范围为 75%(95%CI 67-82)至 100%(95%CI 80-100)。由于所研究人群和所使用方法的差异,异质性很高。
甘露醇试验准确性的研究存在异质性。总体特异性高于敏感性,因此甘露醇试验似乎是一种确认哮喘的合适诊断工具。然而,纳入研究之间的高度异质性使得很难对甘露醇试验的准确性做出结论性的陈述,需要进一步的研究。由于支气管激发试验在哮喘诊断可能性处于中间水平的患者中尤其有用,因此需要进一步的研究,包括有哮喘症状但哮喘诊断可能性处于中间水平的患者。